{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:53:17Z","timestamp":1784008397427,"version":"3.55.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hubei Provincial Health Science and Technology Project","award":["WJ2025M098"],"award-info":[{"award-number":["WJ2025M098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03623-y","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:00:25Z","timestamp":1767636025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Application of nanoparticles in the therapeutic management of endometrial cancer"],"prefix":"10.1186","volume":"31","author":[{"given":"Da","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"3623_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90111-7","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983. https:\/\/doi.org\/10.1016\/0090-8258(83)90111-7.","journal-title":"Gynecol Oncol"},{"key":"3623_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70591-6","author":"R Murali","year":"2014","unstructured":"Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014. https:\/\/doi.org\/10.1016\/S1470-2045(13)70591-6.","journal-title":"Lancet Oncol"},{"key":"3623_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000832","author":"CM Eakin","year":"2023","unstructured":"Eakin CM, Lai T, Cohen JG. Alarming trends and disparities in high-risk endometrial cancer. Curr Opin Obstet Gynecol. 2023. https:\/\/doi.org\/10.1097\/GCO.0000000000000832.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"3623_CR4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21440","author":"F Islami","year":"2018","unstructured":"Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018. https:\/\/doi.org\/10.3322\/caac.21440.","journal-title":"CA Cancer J Clin"},{"key":"3623_CR5","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1994.1261","author":"KF McGonigle","year":"1994","unstructured":"McGonigle KF, Karlan BY, Barbuto DA, Leuchter RS, Lagasse LD, Judd HL. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy. Gynecol Oncol. 1994. https:\/\/doi.org\/10.1006\/gyno.1994.1261.","journal-title":"Gynecol Oncol"},{"key":"3623_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws309","author":"L Dossus","year":"2013","unstructured":"Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S, et al. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort\u2013a factor analysis. Am J Epidemiol. 2013. https:\/\/doi.org\/10.1093\/aje\/kws309.","journal-title":"Am J Epidemiol"},{"key":"3623_CR7","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-13-0020","author":"KH Lu","year":"2013","unstructured":"Lu KH, Loose DS, Yates MS, Nogueras-Gonzalez GM, Munsell MF, Chen LM, et al. Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome. Cancer Prev Res. 2013. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-13-0020.","journal-title":"Cancer Prev Res"},{"key":"3623_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70145-5","author":"M Janda","year":"2010","unstructured":"Janda M, Gebski V, Brand A, Hogg R, Jobling TW, Land R, et al. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncol. 2010. https:\/\/doi.org\/10.1016\/S1470-2045(10)70145-5.","journal-title":"Lancet Oncol"},{"key":"3623_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2004.05.006","author":"L Fokdal","year":"2004","unstructured":"Fokdal L, Hoyer M, Meldgaard P, von der Maase H. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol. 2004. https:\/\/doi.org\/10.1016\/j.radonc.2004.05.006.","journal-title":"Radiother Oncol"},{"key":"3623_CR10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01076","author":"DS Miller","year":"2020","unstructured":"Miller DS, Filiaci VL, Mannel RS, Cohn DE, Matsumoto T, Tewari KS, et al. Carboplatin and paclitaxel for advanced endometrial cancer: final overall survival and adverse event analysis of a phase III trial (NRG Oncology\/GOG0209). J Clin Oncol. 2020. https:\/\/doi.org\/10.1200\/JCO.20.01076.","journal-title":"J Clin Oncol"},{"key":"3623_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/107327480901600106","author":"SM Temkin","year":"2009","unstructured":"Temkin SM, Fleming G. Current treatment of metastatic endometrial cancer. Cancer Control. 2009. https:\/\/doi.org\/10.1177\/107327480901600106.","journal-title":"Cancer Control"},{"key":"3623_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1672455","author":"JW Roh","year":"2020","unstructured":"Roh JW, Choi JE, Han HD, Hu W, Matsuo K, Nishimura M, et al. Clinical and biological significance of EZH2 expression in endometrial cancer. Cancer Biol Ther. 2020. https:\/\/doi.org\/10.1080\/15384047.2019.1672455.","journal-title":"Cancer Biol Ther"},{"key":"3623_CR13","doi-asserted-by":"publisher","DOI":"10.1039\/c4nr04624b","author":"M Kaur","year":"2014","unstructured":"Kaur M, Healy J, Vasudevamurthy M, Lasse M, Puskar L, Tobin MJ, et al. Stability and cytotoxicity of crystallin amyloid nanofibrils. Nanoscale. 2014. https:\/\/doi.org\/10.1039\/c4nr04624b.","journal-title":"Nanoscale"},{"key":"3623_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.08.014","author":"J Bi","year":"2019","unstructured":"Bi J, Areecheewakul S, Li Y, Yang S, Zhang Y, Ebeid K, et al. MTDH\/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. Gynecol Oncol. 2019. https:\/\/doi.org\/10.1016\/j.ygyno.2019.08.014.","journal-title":"Gynecol Oncol"},{"key":"3623_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6528572","author":"X Liu","year":"2020","unstructured":"Liu X, Yang X, Shao J, Hong Y, Gopinath SCB, Chen Y, et al. Coordination of nanoconjugation with an antigen\/antibody for efficient detection of gynecological tumors. J Anal Methods Chem. 2020. https:\/\/doi.org\/10.1155\/2020\/6528572.","journal-title":"J Anal Methods Chem"},{"key":"3623_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2021.1926275","author":"A Chinnathambi","year":"2021","unstructured":"Chinnathambi A, Awad Alahmadi T, Ali Alharbi S. Biogenesis of copper nanoparticles (Cu-NPs) using leaf extract of Allium noeanum, antioxidant and in-vitro cytotoxicity. Artif Cells Nanomed Biotechnol. 2021. https:\/\/doi.org\/10.1080\/21691401.2021.1926275.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3623_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-024-04747-4","author":"N Kumar","year":"2025","unstructured":"Kumar N, Mangla M. Nanotechnology and nanobots unleashed: pioneering a new era in gynecological cancer management - a comprehensive review. Cancer Chemother Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00280-024-04747-4.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3623_CR18","doi-asserted-by":"publisher","DOI":"10.1039\/c9tb02377a","author":"H Halim","year":"2020","unstructured":"Halim H, Simon J, Lieberwirth I, Mailander V, Koynov K, Riedinger A. Water-dispersed semiconductor nanoplatelets with high fluorescence brightness, chemical and colloidal stability. J Mater Chem B. 2020. https:\/\/doi.org\/10.1039\/c9tb02377a.","journal-title":"J Mater Chem B"},{"key":"3623_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201902673","author":"C Hao","year":"2019","unstructured":"Hao C, Gao R, Li Y, Xu L, Sun M, Xu C, et al. Chiral semiconductor nanoparticles for protein catalysis and profiling. Angew Chem. 2019. https:\/\/doi.org\/10.1002\/anie.201902673.","journal-title":"Angew Chem"},{"key":"3623_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052105","author":"AY Yin","year":"2023","unstructured":"Yin AY, Xu J, Yang CS, Hsu SH. Antiviral and antibacterial sulfated polysaccharide-chitosan nanocomposite particles as a drug carrier. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28052105.","journal-title":"Molecules"},{"key":"3623_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164038","author":"J Lopes-Nunes","year":"2021","unstructured":"Lopes-Nunes J, Agonia AS, Rosado T, Gallardo E, Palmeira-de-Oliveira R, Palmeira-de-Oliveira A, et al. Aptamer-functionalized gold nanoparticles for drug delivery to gynecological carcinoma cells. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13164038.","journal-title":"Cancers (Basel)"},{"key":"3623_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2023.11.143","author":"Z Chen","year":"2024","unstructured":"Chen Z, Shan J, Niu Q, Chen H, Zhang W, Cao D, et al. Ph-responsive double-enzyme active metal-organic framework for promoting the healing of infected wounds. J Colloid Interface Sci. 2024. https:\/\/doi.org\/10.1016\/j.jcis.2023.11.143.","journal-title":"J Colloid Interface Sci"},{"key":"3623_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43870-3","author":"W Jiang","year":"2023","unstructured":"Jiang W, Li Q, Zhang R, Li J, Lin Q, Li J, et al. Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson\u2019s disease. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-43870-3.","journal-title":"Nat Commun"},{"key":"3623_CR24","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21199","author":"AS Thakor","year":"2013","unstructured":"Thakor AS, Gambhir SS. Nanooncology: the future of cancer diagnosis and therapy. CA Cancer J Clin. 2013. https:\/\/doi.org\/10.3322\/caac.21199.","journal-title":"CA Cancer J Clin"},{"key":"3623_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.121544","author":"T Bharadwaj","year":"2024","unstructured":"Bharadwaj T, Chrungoo S, Verma D. Self-assembled chitosan\/gelatin nanofibrous aggregates incorporated thermosensitive nanocomposite bioink for bone tissue engineering. Carbohydr Polym. 2024. https:\/\/doi.org\/10.1016\/j.carbpol.2023.121544.","journal-title":"Carbohydr Polym"},{"key":"3623_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-023-01533-w","author":"N Krishnan","year":"2023","unstructured":"Krishnan N, Jiang Y, Zhou J, Mohapatra A, Peng FX, Duan Y, et al. A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering. Nat Nanotechnol. 2023. https:\/\/doi.org\/10.1038\/s41565-023-01533-w.","journal-title":"Nat Nanotechnol"},{"key":"3623_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2018.09.045","author":"P Xue","year":"2018","unstructured":"Xue P, Hou M, Sun L, Li Q, Zhang L, Xu Z, et al. Calcium-carbonate packaging magnetic polydopamine nanoparticles loaded with indocyanine green for near-infrared induced photothermal\/photodynamic therapy. Acta Biomater. 2018. https:\/\/doi.org\/10.1016\/j.actbio.2018.09.045.","journal-title":"Acta Biomater"},{"key":"3623_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195905","author":"S Adepu","year":"2021","unstructured":"Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26195905.","journal-title":"Molecules"},{"key":"3623_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-023-01513-0","author":"C Ye","year":"2023","unstructured":"Ye C, Wang M, Min J, Tay RY, Lukas H, Sempionatto JR, et al. A wearable aptamer nanobiosensor for non-invasive female hormone monitoring. Nat Nanotechnol. 2023. https:\/\/doi.org\/10.1038\/s41565-023-01513-0.","journal-title":"Nat Nanotechnol"},{"key":"3623_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306230","author":"X Song","year":"2024","unstructured":"Song X, Cai H, Shi Z, Li Z, Zheng X, Yang K, et al. Enzyme-responsive branched glycopolymer-based nanoassembly for co-delivery of paclitaxel and Akt inhibitor toward synergistic therapy of gastric cancer. Adv Sci. 2024. https:\/\/doi.org\/10.1002\/advs.202306230.","journal-title":"Adv Sci"},{"key":"3623_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01654-w","author":"H Li","year":"2024","unstructured":"Li H, Qian X, Mohanram H, Han X, Qi H, Zou G, et al. Self-assembly of peptide nanocapsules by a solvent concentration gradient. Nat Nanotechnol. 2024. https:\/\/doi.org\/10.1038\/s41565-024-01654-w.","journal-title":"Nat Nanotechnol"},{"key":"3623_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12195-025-00853-2","author":"LDP Cuatin","year":"2025","unstructured":"Cuatin LDP, Zhang D, Zertuche F, Mota L, Dang C, Nayak B, et al. Developing nanoparticle-based therapeutics for targeting the microenvironment in obesity-induced endometrial cancer. Cell Mol Bioeng. 2025. https:\/\/doi.org\/10.1007\/s12195-025-00853-2.","journal-title":"Cell Mol Bioeng"},{"key":"3623_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202302931","author":"YW Naguib","year":"2024","unstructured":"Naguib YW, Alhaj-Suliman SO, Wafa EI, Saha S, Ebeid K, Mohammed HHH, et al. Ciprofloxacin derivative-loaded nanoparticles synergize with paclitaxel against type II human endometrial cancer. Small. 2024. https:\/\/doi.org\/10.1002\/smll.202302931.","journal-title":"Small"},{"key":"3623_CR34","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c06028","author":"G Gulbay","year":"2023","unstructured":"Gulbay G, Secme M, Ilhan H. Exploring the potential of thymoquinone-stabilized selenium nanoparticles: in HEC1B endometrial cancer cells revealing enhanced anticancer efficacy. ACS Omega. 2023. https:\/\/doi.org\/10.1021\/acsomega.3c06028.","journal-title":"ACS Omega"},{"key":"3623_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210422","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007. https:\/\/doi.org\/10.1038\/sj.onc.1210422.","journal-title":"Oncogene"},{"issue":"7","key":"3623_CR36","first-page":"1317","volume":"8","author":"F Guo","year":"2018","unstructured":"Guo F, Zhang H, Jia Z, Cui M, Tian J. Chemoresistance and targeting of growth factors\/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer. Am J Cancer Res. 2018;8(7):1317.","journal-title":"Am J Cancer Res"},{"key":"3623_CR37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1683","author":"AA Manzoor","year":"2012","unstructured":"Manzoor AA, Lindner LH, Landon CD, Park JY, Simnick AJ, Dreher MR, et al. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res. 2012. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1683.","journal-title":"Cancer Res"},{"key":"3623_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308033","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Xia YD, Sun YQ, Wang Y, Yin XB. Three-in-one\" nanozyme composite for augmented cascade catalytic tumor therapy. Adv Mater. 2023. https:\/\/doi.org\/10.1002\/adma.202308033.","journal-title":"Adv Mater"},{"key":"3623_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2016.12.015","author":"PJ Bates","year":"2017","unstructured":"Bates PJ, Reyes-Reyes EM, Malik MT, Murphy EM, O\u2019Toole MG, Trent JO. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: uses and mechanisms. Biochimica et Biophysica Acta (BBA)\u2014General Subjects. 2017. https:\/\/doi.org\/10.1016\/j.bbagen.2016.12.015.","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014General Subjects"},{"key":"3623_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/09205063.2021.1974149","author":"J Yang","year":"2022","unstructured":"Yang J, Guo H, Lei J, Zhang S, Zhang S, Bai J, et al. Fabrication of polymer-based self-assembly nanocarriers loaded with a crizotinib and gemcitabine: potential therapeutics for the treatment of endometrial cancer. J Biomater Sci Polym Ed. 2022. https:\/\/doi.org\/10.1080\/09205063.2021.1974149.","journal-title":"J Biomater Sci Polym Ed"},{"key":"3623_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104472","author":"X Yang","year":"2022","unstructured":"Yang X, Cheng Y, Zhou J, Zhang L, Li X, Wang Z, et al. Targeting cancer metabolism plasticity with JX06 nanoparticles via inhibiting PDK1 combined with metformin for endometrial cancer patients with diabetes. Adv Sci. 2022. https:\/\/doi.org\/10.1002\/advs.202104472.","journal-title":"Adv Sci"},{"key":"3623_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123136","author":"M Rizwanullah","year":"2023","unstructured":"Rizwanullah M, Perwez A, Alam M, Ahmad S, Mir SR, Rizvi MMA, et al. Polymer-lipid hybrid nanoparticles of exemestane for improved oral bioavailability and anti-tumor efficacy: an extensive preclinical investigation. Int J Pharm. 2023. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123136.","journal-title":"Int J Pharm"},{"key":"3623_CR43","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ac1098","author":"M Rizwanullah","year":"2021","unstructured":"Rizwanullah M, Perwez A, Mir SR, Alam Rizvi MM, Amin S. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization,in vitrocharacterization and cell culture studies. Nanotechnology. 2021. https:\/\/doi.org\/10.1088\/1361-6528\/ac1098.","journal-title":"Nanotechnology"},{"key":"3623_CR44","doi-asserted-by":"publisher","DOI":"10.3762\/bjnano.15.118","author":"I Rahat","year":"2024","unstructured":"Rahat I, Yadav P, Singhal A, Fareed M, Purushothaman JR, Aslam M, et al. Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects. Beilstein J Nanotechnol. 2024. https:\/\/doi.org\/10.3762\/bjnano.15.118.","journal-title":"Beilstein J Nanotechnol"},{"key":"3623_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2004.02.014","author":"L Brannon-Peppas","year":"2004","unstructured":"Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004. https:\/\/doi.org\/10.1016\/j.addr.2004.02.014.","journal-title":"Adv Drug Deliv Rev"},{"key":"3623_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.04.009","author":"J Fang","year":"2011","unstructured":"Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011. https:\/\/doi.org\/10.1016\/j.addr.2010.04.009.","journal-title":"Adv Drug Deliv Rev"},{"key":"3623_CR47","doi-asserted-by":"publisher","DOI":"10.1039\/d0bm00112k","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang X, Chen C, Huang Y, Yu X, Li X. Ultra pH-sensitive polymeric nanovesicles co-deliver doxorubicin and navitoclax for synergetic therapy of endometrial carcinoma. Biomater Sci. 2020. https:\/\/doi.org\/10.1039\/d0bm00112k.","journal-title":"Biomater Sci"},{"key":"3623_CR48","doi-asserted-by":"publisher","DOI":"10.1039\/d1tb01883c","author":"F An","year":"2021","unstructured":"An F, Xin J, Deng C, Tan X, Aras O, Chen N, et al. Facile synthesis of near-infrared bodipy by donor engineering for in vivo tumor targeted dual-modal imaging. J Mater Chem B. 2021. https:\/\/doi.org\/10.1039\/d1tb01883c.","journal-title":"J Mater Chem B"},{"key":"3623_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2591","author":"RA Petros","year":"2010","unstructured":"Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010. https:\/\/doi.org\/10.1038\/nrd2591.","journal-title":"Nat Rev Drug Discov"},{"key":"3623_CR50","doi-asserted-by":"publisher","DOI":"10.1021\/bm5003009","author":"Y Zhong","year":"2014","unstructured":"Zhong Y, Meng F, Deng C, Zhong Z. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Biomacromol. 2014. https:\/\/doi.org\/10.1021\/bm5003009.","journal-title":"Biomacromol"},{"key":"3623_CR51","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.3c08032","author":"Q Feng","year":"2023","unstructured":"Feng Q, Fang W, Guo Y, Hu P, Shi J. Nebulized therapy of early orthotopic lung cancer by iron-based nanoparticles: macrophage-regulated ferroptosis of cancer stem cells. J Am Chem Soc. 2023. https:\/\/doi.org\/10.1021\/jacs.3c08032.","journal-title":"J Am Chem Soc"},{"key":"3623_CR52","doi-asserted-by":"publisher","DOI":"10.1039\/c2cs15344k","author":"N Kamaly","year":"2012","unstructured":"Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012. https:\/\/doi.org\/10.1039\/c2cs15344k.","journal-title":"Chem Soc Rev"},{"key":"3623_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.02.034","author":"C Vilos","year":"2013","unstructured":"Vilos C, Morales FA, Solar PA, Herrera NS, Gonzalez-Nilo FD, Aguayo DA, et al. Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials. 2013. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.02.034.","journal-title":"Biomaterials"},{"key":"3623_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-01065-7","author":"K Wiwatchaitawee","year":"2022","unstructured":"Wiwatchaitawee K, Mekkawy AI, Quarterman JC, Naguib YW, Ebeid K, Geary SM, et al. The MEK 1\/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles. Drug Deliv Transl Res. 2022. https:\/\/doi.org\/10.1007\/s13346-021-01065-7.","journal-title":"Drug Deliv Transl Res"},{"key":"3623_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400476","author":"AG Porter","year":"1999","unstructured":"Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999. https:\/\/doi.org\/10.1038\/sj.cdd.4400476.","journal-title":"Cell Death Differ"},{"key":"3623_CR56","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053010","author":"S Nagata","year":"2018","unstructured":"Nagata S. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol. 2018. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053010.","journal-title":"Annu Rev Immunol"},{"key":"3623_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6631533","author":"Q Hu","year":"2021","unstructured":"Hu Q, Zhang S, Zhu J, Yin L, Liu S, Huang X, et al. The promotional effect of hollow MnO(2) with Brucea Javanica Oil Emulsion (BJOE) on endometrial cancer apoptosis. Biomed Res Int. 2021. https:\/\/doi.org\/10.1155\/2021\/6631533.","journal-title":"Biomed Res Int"},{"key":"3623_CR58","doi-asserted-by":"publisher","DOI":"10.1021\/cr400532z","author":"L Cheng","year":"2014","unstructured":"Cheng L, Wang C, Feng L, Yang K, Liu Z. Functional nanomaterials for phototherapies of cancer. Chem Rev. 2014. https:\/\/doi.org\/10.1021\/cr400532z.","journal-title":"Chem Rev"},{"key":"3623_CR59","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/59448833","author":"S Jain","year":"2012","unstructured":"Jain S, Hirst DG, O\u2019Sullivan JM. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 2012. https:\/\/doi.org\/10.1259\/bjr\/59448833.","journal-title":"Br J Radiol"},{"key":"3623_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31826f6806","author":"SA Byron","year":"2012","unstructured":"Byron SA, Loch DC, Pollock PM. Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells. Int J Gynecol Cancer. 2012. https:\/\/doi.org\/10.1097\/IGC.0b013e31826f6806.","journal-title":"Int J Gynecol Cancer"},{"key":"3623_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210529","author":"PM Pollock","year":"2007","unstructured":"Pollock PM, Gartside MG, Dejeza LC, Powell MA, Mallon MA, Davies H, et al. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene. 2007. https:\/\/doi.org\/10.1038\/sj.onc.1210529.","journal-title":"Oncogene"},{"key":"3623_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.09.017","author":"AE Fearon","year":"2013","unstructured":"Fearon AE, Gould CR, Grose RP. FGFR signalling in women\u2019s cancers. Int J Biochem Cell Biol. 2013. https:\/\/doi.org\/10.1016\/j.biocel.2013.09.017.","journal-title":"Int J Biochem Cell Biol"},{"key":"3623_CR63","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2021.0214","author":"B Barczynski","year":"2022","unstructured":"Barczynski B, Fraszczak K, Bednarek W. Sentinel lymph node mapping in endometrial cancer after 2020 ESGO-ESTRO-ESP consensus update: what will happen in the next few years? Ginekol Pol. 2022. https:\/\/doi.org\/10.5603\/GP.a2021.0214.","journal-title":"Ginekol Pol"},{"key":"3623_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.09.026","author":"R Dinniwell","year":"2009","unstructured":"Dinniwell R, Chan P, Czarnota G, Haider MA, Jhaveri K, Jewett M, et al. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2009. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.09.026.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3623_CR65","doi-asserted-by":"publisher","DOI":"10.20935\/AcadNano7563","author":"SB Majee","year":"2025","unstructured":"Majee SB, Avlani D, Kumar A, Bera R. Harnessing nanotheranostics for the management of breast and ovarian cancer. Acad Nano Sci Mater Technol. 2025. https:\/\/doi.org\/10.20935\/AcadNano7563.","journal-title":"Acad Nano Sci Mater Technol."},{"key":"3623_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-02922-0","author":"S Tao","year":"2023","unstructured":"Tao S, Zhang Z, Li L, Yuan X, Chen H, Zhang Y, et al. Characteristics of systematic lymph node dissection and influencing factors of sentinel lymph node biopsy using carbon nanoparticles in endometrial carcinoma: a single-center study. World J Surg Oncol. 2023. https:\/\/doi.org\/10.1186\/s12957-023-02922-0.","journal-title":"World J Surg Oncol"},{"key":"3623_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-023-07111-8","author":"J Chen","year":"2023","unstructured":"Chen J, Liang S, He M, Wang Z, Deng H, Zhang G, et al. Comparison of sentinel lymph node distribution and lymphatic drainage pathway between high- and low-risk endometrial cancers. Arch Gynecol Obstet. 2023. https:\/\/doi.org\/10.1007\/s00404-023-07111-8.","journal-title":"Arch Gynecol Obstet"},{"key":"3623_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26100","author":"Y Wang","year":"2020","unstructured":"Wang Y, Dan Z, Yuan G, Zhang G, Liu S, Zhang Y, et al. Detection of sentinel lymph node in laparoscopic surgery for uterine cervical cancer using carbon nanoparticles. J Surg Oncol. 2020. https:\/\/doi.org\/10.1002\/jso.26100.","journal-title":"J Surg Oncol"},{"key":"3623_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27268","author":"M He","year":"2023","unstructured":"He M, Liang S, Deng H, Zhang G, Wang Z, Yang X, et al. Comparing carbon nanoparticles and indocyanine green for sentinel lymph node mapping in endometrial cancer: a randomized-controlled single-center trial. J Surg Oncol. 2023. https:\/\/doi.org\/10.1002\/jso.27268.","journal-title":"J Surg Oncol"},{"key":"3623_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.012","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012.","journal-title":"Immunity"},{"key":"3623_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3380","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012. https:\/\/doi.org\/10.1038\/nrc3380.","journal-title":"Nat Rev Cancer"},{"key":"3623_CR72","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c09521","author":"M Li","year":"2023","unstructured":"Li M, Yang L, Wang C, Cui M, Wen Z, Liao Z, et al. Rapid induction of long-lasting systemic and mucosal immunity via thermostable microneedle-mediated chitosan oligosaccharide-encapsulated DNA nanoparticles. ACS Nano. 2023. https:\/\/doi.org\/10.1021\/acsnano.3c09521.","journal-title":"ACS Nano"},{"key":"3623_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201804882","author":"X Duan","year":"2019","unstructured":"Duan X, Chan C, Lin W. Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy. Angew Chem. 2019. https:\/\/doi.org\/10.1002\/anie.201804882.","journal-title":"Angew Chem"},{"key":"3623_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2015.08.004","author":"J Rios-Doria","year":"2015","unstructured":"Rios-Doria J, Durham N, Wetzel L, Rothstein R, Chesebrough J, Holoweckyj N, et al. Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models. Neoplasia. 2015. https:\/\/doi.org\/10.1016\/j.neo.2015.08.004.","journal-title":"Neoplasia"},{"key":"3623_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.06.032","author":"X Zhao","year":"2016","unstructured":"Zhao X, Yang K, Zhao R, Ji T, Wang X, Yang X, et al. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy. Biomaterials. 2016. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.06.032.","journal-title":"Biomaterials"},{"key":"3623_CR76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215091120","author":"ME Distler","year":"2023","unstructured":"Distler ME, Cavaliere JP, Teplensky MH, Evangelopoulos M, Mirkin CA. Molecular DNA dendron vaccines. Proc Natl Acad Sci U S A. 2023. https:\/\/doi.org\/10.1073\/pnas.2215091120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3623_CR77","doi-asserted-by":"publisher","DOI":"10.2174\/1871520621666210608095512","author":"BM Sahoo","year":"2022","unstructured":"Sahoo BM, Banik BK, Borah P, Jain A. Reactive oxygen species (ROS): key components in cancer therapies. Anticancer Agents Med Chem. 2022. https:\/\/doi.org\/10.2174\/1871520621666210608095512.","journal-title":"Anticancer Agents Med Chem"},{"key":"3623_CR78","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4466","author":"IM Chung","year":"2017","unstructured":"Chung IM, Abdul Rahuman A, Marimuthu S, Kirthi AV, Anbarasan K, Padmini P, et al. Green synthesis of copper nanoparticles using Eclipta prostrata leaves extract and their antioxidant and cytotoxic activities. Exp Ther Med. 2017. https:\/\/doi.org\/10.3892\/etm.2017.4466.","journal-title":"Exp Ther Med"},{"key":"3623_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2018.04.014","author":"IA Radini","year":"2018","unstructured":"Radini IA, Hasan N, Malik MA, Khan Z. Biosynthesis of iron nanoparticles using Trigonella foenum-graecum seed extract for photocatalytic methyl orange dye degradation and antibacterial applications. J Photochem Photobiol B Biol. 2018. https:\/\/doi.org\/10.1016\/j.jphotobiol.2018.04.014.","journal-title":"J Photochem Photobiol B Biol"},{"key":"3623_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-017-0009-7","author":"K Ebeid","year":"2018","unstructured":"Ebeid K, Meng X, Thiel KW, Do AV, Geary SM, Morris AS, et al. Synthetically lethal nanoparticles for treatment of endometrial cancer. Nat Nanotechnol. 2018. https:\/\/doi.org\/10.1038\/s41565-017-0009-7.","journal-title":"Nat Nanotechnol"},{"key":"3623_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122093","author":"SO Alhaj-Suliman","year":"2023","unstructured":"Alhaj-Suliman SO, Naguib YW, Wafa EI, Saha S, Ebeid K, Meng X, et al. A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer. Biomaterials. 2023. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122093.","journal-title":"Biomaterials"},{"key":"3623_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164032","author":"K Edwards","year":"2021","unstructured":"Edwards K, Yao S, Pisano S, Feltracco V, Brusehafer K, Samanta S, et al. Hyaluronic acid-functionalized nanomicelles enhance SAHA efficacy in 3D endometrial cancer models. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13164032.","journal-title":"Cancers"},{"key":"3623_CR83","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S329341","author":"X Gong","year":"2021","unstructured":"Gong X, Pu X, Wang J, Yang L, Cui Y, Li L, et al. Enhancing of nanocatalyst-driven chemodynaminc therapy for endometrial cancer cells through inhibition of PINK1\/Parkin-mediated mitophagy. Int J Nanomedicine. 2021. https:\/\/doi.org\/10.2147\/IJN.S329341.","journal-title":"Int J Nanomedicine"},{"key":"3623_CR84","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S200480","author":"Y Gao","year":"2019","unstructured":"Gao Y, Qian H, Tang X, Du X, Wang G, Zhang H, et al. Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth. Int J Nanomedicine. 2019. https:\/\/doi.org\/10.2147\/IJN.S200480.","journal-title":"Int J Nanomedicine"},{"key":"3623_CR85","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S83838","author":"H Wang","year":"2015","unstructured":"Wang H, Liu Z, Gou Y, Qin Y, Xu Y, Liu J, et al. Apoptosis and necrosis induced by novel realgar quantum dots in human endometrial cancer cells via endoplasmic reticulum stress signaling pathway. Int J Nanomedicine. 2015. https:\/\/doi.org\/10.2147\/IJN.S83838.","journal-title":"Int J Nanomedicine"},{"key":"3623_CR86","doi-asserted-by":"publisher","DOI":"10.7150\/thno.31225","author":"L Philp","year":"2019","unstructured":"Philp L, Chan H, Rouzbahman M, Overchuk M, Chen J, Zheng G, et al. Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancer. Theranostics. 2019. https:\/\/doi.org\/10.7150\/thno.31225.","journal-title":"Theranostics"},{"key":"3623_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2018.11.002","author":"J Zuo","year":"2019","unstructured":"Zuo J, Wu LY, Cheng M, Bai P, Lei CZ, Li N, et al. Comparison study of laparoscopic sentinel lymph node mapping in endometrial carcinoma using carbon nanoparticles and lymphatic pathway verification. J Minim Invasive Gynecol. 2019. https:\/\/doi.org\/10.1016\/j.jmig.2018.11.002.","journal-title":"J Minim Invasive Gynecol"},{"key":"3623_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26518","author":"S Liang","year":"2021","unstructured":"Liang S, Wang Z, Chen J, Yang X, Liang X, Sun X, et al. Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma. J Surg Oncol. 2021. https:\/\/doi.org\/10.1002\/jso.26518.","journal-title":"J Surg Oncol"},{"key":"3623_CR89","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002064","author":"C Feng","year":"2025","unstructured":"Feng C, Jiang X, Feng L, Sun W, Liu Q, Hao Y, et al. Comparison of different tracers in sentinel lymph node detection for endometrial cancer: a systematic review and network meta-analysis. Int J Surg. 2025. https:\/\/doi.org\/10.1097\/JS9.0000000000002064.","journal-title":"Int J Surg"},{"key":"3623_CR90","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.166","author":"AG Rockall","year":"2005","unstructured":"Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol. 2005. https:\/\/doi.org\/10.1200\/JCO.2005.07.166.","journal-title":"J Clin Oncol"},{"key":"3623_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020781","author":"MA Jedryka","year":"2025","unstructured":"Jedryka MA, Klimczak P, Kryszpin M, Poprawski T, Czekanski A, Lepka P, et al. Superparamagnetic iron oxide nanoparticles as a tracer for sentinel lymph node mapping in endometrial cancer. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26020781.","journal-title":"Int J Mol Sci"},{"key":"3623_CR92","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.4c03726","author":"H Yang","year":"2024","unstructured":"Yang H, Wu P, Li B, Huang X, Shi Q, Qiao L, et al. Diagnosis and biomarker screening of endometrial cancer enabled by a versatile exosome metabolic fingerprint platform. Anal Chem. 2024. https:\/\/doi.org\/10.1021\/acs.analchem.4c03726.","journal-title":"Anal Chem"},{"key":"3623_CR93","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1998.00910.x","author":"RJ Steele","year":"1998","unstructured":"Steele RJ, Thompson AM, Hall PA, Lane DP. The p53 tumour suppressor gene. Br J Surg. 1998. https:\/\/doi.org\/10.1046\/j.1365-2168.1998.00910.x.","journal-title":"Br J Surg"},{"key":"3623_CR94","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000871","author":"G Beinse","year":"2020","unstructured":"Beinse G, Rance B, Just PA, Izac B, Letourneur F, Saidu NEB, et al. Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments. Int J Gynecol Cancer. 2020. https:\/\/doi.org\/10.1136\/ijgc-2019-000871.","journal-title":"Int J Gynecol Cancer"},{"key":"3623_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.43","author":"E Stelloo","year":"2015","unstructured":"Stelloo E, Bosse T, Nout RA, MacKay HJ, Church DN, Nijman HW, et al. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Mod Pathol. 2015. https:\/\/doi.org\/10.1038\/modpathol.2015.43.","journal-title":"Mod Pathol"},{"key":"3623_CR96","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw1565","author":"N Kong","year":"2019","unstructured":"Kong N, Tao W, Ling X, Wang J, Xiao Y, Shi S, et al. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition. Sci Transl Med. 2019. https:\/\/doi.org\/10.1126\/scitranslmed.aaw1565.","journal-title":"Sci Transl Med"},{"key":"3623_CR97","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/709736","author":"A Pavlidou","year":"2014","unstructured":"Pavlidou A, Vlahos NF. Molecular alterations of PI3K\/Akt\/mTOR pathway: a therapeutic target in endometrial cancer. TheScientificWorldJOURNAL. 2014. https:\/\/doi.org\/10.1155\/2014\/709736.","journal-title":"TheScientificWorldJOURNAL"},{"key":"3623_CR98","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1558202","author":"F Barra","year":"2019","unstructured":"Barra F, Evangelisti G, Ferro Desideri L, Di Domenico S, Ferraioli D, Vellone VG, et al. Investigational PI3K\/AKT\/mTOR inhibitors in development for endometrial cancer. Expert Opin Investig Drugs. 2019. https:\/\/doi.org\/10.1080\/13543784.2018.1558202.","journal-title":"Expert Opin Investig Drugs"},{"key":"3623_CR99","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10121","author":"X Shi","year":"2019","unstructured":"Shi X, Wang J, Lei Y, Cong C, Tan D, Zhou X. Research progress on the PI3K\/AKT signaling pathway in gynecological cancer (Review). Mol Med Rep. 2019. https:\/\/doi.org\/10.3892\/mmr.2019.10121.","journal-title":"Mol Med Rep"},{"key":"3623_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051868","author":"MA Rahman","year":"2025","unstructured":"Rahman MA, Jalouli M, Bhajan SK, Al-Zharani M, Harrath AH. A comprehensive review of nanoparticle-based drug delivery for modulating PI3K\/AKT\/mTOR-mediated autophagy in cancer. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26051868.","journal-title":"Int J Mol Sci"},{"key":"3623_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093320","author":"NN Mahmoud","year":"2020","unstructured":"Mahmoud NN, Abuarqoub D, Zaza R, Sabbah DA, Khalil EA, Abu-Dahab R. Gold nanocomplex strongly modulates the PI3K\/Akt pathway and other pathways in MCF-7 breast cancer cell line. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21093320.","journal-title":"Int J Mol Sci"},{"key":"3623_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.12.004","author":"J das Neves","year":"2015","unstructured":"das Neves J, Nunes R, Machado A, Sarmento B. Polymer-based nanocarriers for vaginal drug delivery. Adv Drug Deliv Rev. 2015. https:\/\/doi.org\/10.1016\/j.addr.2014.12.004.","journal-title":"Adv Drug Deliv Rev"},{"key":"3623_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114543","author":"RL Shapiro","year":"2022","unstructured":"Shapiro RL, DeLong K, Zulfiqar F, Carter D, Better M, Ensign LM. In vitro and ex vivo models for evaluating vaginal drug delivery systems. Adv Drug Deliv Rev. 2022. https:\/\/doi.org\/10.1016\/j.addr.2022.114543.","journal-title":"Adv Drug Deliv Rev"},{"key":"3623_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.04.033","author":"LM Ensign","year":"2014","unstructured":"Ensign LM, Cone R, Hanes J. Nanoparticle-based drug delivery to the vagina: a review. J Control Release. 2014. https:\/\/doi.org\/10.1016\/j.jconrel.2014.04.033.","journal-title":"J Control Release"},{"key":"3623_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119616","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zhang Y, Wang Z, Guo T, Hou X, He Z, et al. Temperature-sensitive gel-loaded composite nanomedicines for the treatment of cervical cancer by vaginal delivery. Int J Pharm. 2020. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119616.","journal-title":"Int J Pharm"},{"key":"3623_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303134","author":"R Navaridas","year":"2023","unstructured":"Navaridas R, Vidal-Sabanes M, Ruiz-Mitjana A, Altes G, Perramon-Guell A, Yeramian A, et al. In vivo intra-uterine delivery of TAT-Fused Cre Recombinase and CRISPR\/Cas9 editing system in mice unveil histopathology of Pten\/p53-deficient endometrial cancers. Adv Sci. 2023. https:\/\/doi.org\/10.1002\/advs.202303134.","journal-title":"Adv Sci"},{"key":"3623_CR107","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju245","author":"Y Liu","year":"2014","unstructured":"Liu Y, Patel L, Mills GB, Lu KH, Sood AK, Ding L, et al. Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma. J Natl Cancer Inst. 2014. https:\/\/doi.org\/10.1093\/jnci\/dju245.","journal-title":"J Natl Cancer Inst"},{"key":"3623_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.09.005","author":"S Ganesh","year":"2018","unstructured":"Ganesh S, Shui X, Craig KP, Park J, Wang W, Brown BD, et al. RNAi-Mediated \u03b2-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade. Mol Ther. 2018. https:\/\/doi.org\/10.1016\/j.ymthe.2018.09.005.","journal-title":"Mol Ther"},{"key":"3623_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/S1028-4559(08)60102-3","author":"FS Liu","year":"2007","unstructured":"Liu FS. Molecular carcinogenesis of endometrial cancer. Taiwan J Obstet Gynecol. 2007. https:\/\/doi.org\/10.1016\/S1028-4559(08)60102-3.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"3623_CR110","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba9772","author":"YX Lin","year":"2021","unstructured":"Lin YX, Wang Y, Ding J, Jiang A, Wang J, Yu M, et al. Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models. Sci Transl Med. 2021. https:\/\/doi.org\/10.1126\/scitranslmed.aba9772.","journal-title":"Sci Transl Med"},{"key":"3623_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124519","author":"J Sam Lee","year":"2024","unstructured":"Sam Lee J, Kim M, Jin H, Kwak M, Cho E, Kim KS, et al. DNA aptamer-conjugated lipid nanoparticle for targeted PTEN mRNA delivery to prostate cancer cells. Int J Pharm. 2024. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124519.","journal-title":"Int J Pharm"},{"key":"3623_CR112","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e46","author":"C Di Tucci","year":"2019","unstructured":"Di Tucci C, Capone C, Galati G, Iacobelli V, Schiavi MC, Di Donato V, et al. Immunotherapy in endometrial cancer: new scenarios on the horizon. J Gynecol Oncol. 2019. https:\/\/doi.org\/10.3802\/jgo.2019.30.e46.","journal-title":"J Gynecol Oncol"},{"key":"3623_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202404941","author":"Y Cao","year":"2024","unstructured":"Cao Y, Zhong X, Wu N, Wan L, Tang R, He H, et al. An ultrasound-responsive and in situ gelling hydrogel nanocomposite for boosting anti PD-L1 immunotherapy via remodeling aberrant ECM of post-surgical residual cancer. Adv Funct Mater. 2024. https:\/\/doi.org\/10.1002\/adfm.202404941.","journal-title":"Adv Funct Mater"},{"key":"3623_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202212267","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, Zhao Q, Wang W, Yin L, et al. Cuproptosis induced by ROS responsive nanoparticles with Elesclomol and copper combined with \u03b1PD\u2010L1 for enhanced cancer immunotherapy. Adv Mater. 2023. https:\/\/doi.org\/10.1002\/adma.202212267.","journal-title":"Adv Mater"},{"key":"3623_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37328-9","author":"P Zhang","year":"2023","unstructured":"Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, et al. STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-37328-9.","journal-title":"Nat Commun"},{"key":"3623_CR116","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21772","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA Cancer J Clin"},{"key":"3623_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.07.018","author":"SA Enazy","year":"2023","unstructured":"Enazy SA, Kirschen GW, Vincent K, Yang J, Saada J, Shah M, et al. PEGylated polymeric nanoparticles loaded with 2-methoxyestradiol for the treatment of uterine leiomyoma in a patient-derived xenograft mouse model. J Pharm Sci. 2023. https:\/\/doi.org\/10.1016\/j.xphs.2023.07.018.","journal-title":"J Pharm Sci"},{"key":"3623_CR118","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1549219","author":"T Miyamoto","year":"2019","unstructured":"Miyamoto T, Shiozawa T. Two-sided role of estrogen on endometrial carcinogenesis: stimulator or suppressor? Gynecol Endocrinol. 2019. https:\/\/doi.org\/10.1080\/09513590.2018.1549219.","journal-title":"Gynecol Endocrinol"},{"key":"3623_CR119","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-43139-0_1","author":"AS Felix","year":"2017","unstructured":"Felix AS, Yang HP, Bell DW, Sherman ME. Epidemiology of endometrial carcinoma: etiologic importance of hormonal and metabolic influences. Adv Exp Med Biol. 2017. https:\/\/doi.org\/10.1007\/978-3-319-43139-0_1.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"3623_CR120","first-page":"1","volume":"5","author":"K Shubhika","year":"2013","unstructured":"Shubhika K. Nanotechnology and medicine\u2014the upside and the downside. Int J Drug Dev Res. 2013;5(1):1\u201310.","journal-title":"Int J Drug Dev Res."},{"key":"3623_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.09.003","author":"G Miao","year":"2023","unstructured":"Miao G, He Y, Lai K, Zhao Y, He P, Tan G, et al. Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients. J Control Release. 2023. https:\/\/doi.org\/10.1016\/j.jconrel.2023.09.003.","journal-title":"J Control Release"},{"key":"3623_CR122","doi-asserted-by":"publisher","DOI":"10.3402\/nano.v1i0.5358","author":"N Singh","year":"2010","unstructured":"Singh N, Jenkins GJ, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010. https:\/\/doi.org\/10.3402\/nano.v1i0.5358.","journal-title":"Nano Rev"},{"key":"3623_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2007.01.043","author":"TR Pisanic","year":"2007","unstructured":"Pisanic TR, Blackwell JD, Shubayev VI, Finones RR, Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials. 2007. https:\/\/doi.org\/10.1016\/j.biomaterials.2007.01.043.","journal-title":"Biomaterials"},{"key":"3623_CR124","first-page":"1","volume-title":"Liposome-based drug delivery systems","author":"M Lin","year":"2019","unstructured":"Lin M, Wang R, Qi X-R. Quality evaluation of drug-loaded liposomes. In: Lu W-L, Qi X-R, editors. Liposome-based drug delivery systems. Berlin, Heidelberg: Springer, Berlin Heidelberg; 2019. p. 1\u201317."},{"key":"3623_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(02)00818-5","author":"P Wust","year":"2002","unstructured":"Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002. https:\/\/doi.org\/10.1016\/s1470-2045(02)00818-5.","journal-title":"Lancet Oncol"},{"key":"3623_CR126","doi-asserted-by":"publisher","DOI":"10.2174\/1389557516666160321114341","author":"F Grande","year":"2016","unstructured":"Grande F, Tucci P. Titanium dioxide nanoparticles: a risk for human health? Mini-Rev Med Chem. 2016. https:\/\/doi.org\/10.2174\/1389557516666160321114341.","journal-title":"Mini-Rev Med Chem"},{"key":"3623_CR127","first-page":"129","volume-title":"Nanomaterial risk assessment and risk management","author":"I Linkov","year":"2008","unstructured":"Linkov I, Satterstrom FK. Nanomaterial risk assessment and risk management. Dordrecht: Springer Netherlands; 2008. p. 129\u201357."},{"key":"3623_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-023-01575-0","author":"YT Qi","year":"2024","unstructured":"Qi YT, Zhang FL, Tian SY, Wu HQ, Zhao Y, Zhang XW, et al. Nanosensor detection of reactive oxygen and nitrogen species leakage in frustrated phagocytosis of nanofibres. Nat Nanotechnol. 2024. https:\/\/doi.org\/10.1038\/s41565-023-01575-0.","journal-title":"Nat Nanotechnol"},{"key":"3623_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2020.111965","author":"MR Bindhu","year":"2020","unstructured":"Bindhu MR, Ancy K, Umadevi M, Esmail GA, Al-Dhabi NA, Arasu MV. Synthesis and characterization of zinc oxide nanostructures and its assessment on enhanced bacterial inhibition and photocatalytic degradation. J Photochem Photobiol B Biol. 2020. https:\/\/doi.org\/10.1016\/j.jphotobiol.2020.111965.","journal-title":"J Photochem Photobiol B Biol"},{"key":"3623_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.5234","author":"R Tahvilian","year":"2019","unstructured":"Tahvilian R, Zangeneh MM, Falahi H, Sadrjavadi K, Jalalvand AR, Zangeneh A. Green synthesis and chemical characterization of copper nanoparticles using Allium saralicum leaves and assessment of their cytotoxicity, antioxidant, antimicrobial, and cutaneous wound healing properties. Appl Organomet Chem. 2019. https:\/\/doi.org\/10.1002\/aoc.5234.","journal-title":"Appl Organomet Chem"},{"key":"3623_CR131","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2016-0305","author":"PL Lam","year":"2017","unstructured":"Lam PL, Wong WY, Bian Z, Chui CH, Gambari R. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern. Nanomedicine. 2017. https:\/\/doi.org\/10.2217\/nnm-2016-0305.","journal-title":"Nanomedicine"},{"key":"3623_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202309096","author":"Z Xu","year":"2023","unstructured":"Xu Z, Jiang J, Li Y, Hu T, Gu J, Zhang P, et al. Shape-regulated photothermal-catalytic tumor therapy using polydopamine@Pt nanozymes with the elicitation of an immune response. Small. 2023. https:\/\/doi.org\/10.1002\/smll.202309096.","journal-title":"Small"},{"key":"3623_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101564","author":"B Zhang","year":"2022","unstructured":"Zhang B, Chen X, Tang G, Zhang R, Li J, Sun G, et al. Constructing a nanocage-based universal carrier for delivering TLR-activating nucleic acids to enhance antitumor immunotherapy. Nano Today. 2022. https:\/\/doi.org\/10.1016\/j.nantod.2022.101564.","journal-title":"Nano Today"},{"key":"3623_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302141","author":"L Xiao","year":"2023","unstructured":"Xiao L, Chen B, Wang W, Tian T, Qian H, Li X, et al. Multifunctional Au@AgBiS(2) nanoparticles as high-efficiency radiosensitizers to induce pyroptosis for cancer radioimmunotherapy. Adv Sci. 2023. https:\/\/doi.org\/10.1002\/advs.202302141.","journal-title":"Adv Sci"},{"key":"3623_CR135","doi-asserted-by":"publisher","DOI":"10.1111\/and.12920","author":"OA Adebayo","year":"2018","unstructured":"Adebayo OA, Akinloye O, Adaramoye OA. Cerium oxide nanoparticle elicits oxidative stress, endocrine imbalance and lowers sperm characteristics in testes of balb\/c mice. Andrologia. 2018. https:\/\/doi.org\/10.1111\/and.12920.","journal-title":"Andrologia"},{"key":"3623_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2012.05.013","author":"ML Etheridge","year":"2013","unstructured":"Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013. https:\/\/doi.org\/10.1016\/j.nano.2012.05.013.","journal-title":"Nanomedicine"},{"key":"3623_CR137","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12403","author":"S Tinkle","year":"2014","unstructured":"Tinkle S, McNeil SE, M\u00fchlebach S, Bawa R, Borchard G, Barenholz YC, et al. Nanomedicines: addressing the scientific and regulatory gap. Ann N Y Acad Sci. 2014. https:\/\/doi.org\/10.1111\/nyas.12403.","journal-title":"Ann N Y Acad Sci"},{"key":"3623_CR138","doi-asserted-by":"publisher","DOI":"10.1080\/02652048.2025.2474457","author":"M Raj","year":"2025","unstructured":"Raj M, Meena A, Seth R, Mathur A, Luqman S. An update on nanoformulations with FDA approved drugs for female reproductive cancer. J Microencapsul. 2025. https:\/\/doi.org\/10.1080\/02652048.2025.2474457.","journal-title":"J Microencapsul"},{"key":"3623_CR139","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-23-3196","author":"E Kalogera","year":"2024","unstructured":"Kalogera E, Nevala WK, Finnes HD, Suman VJ, Schimke JM, Strand CA, et al. A phase I trial of Nab-Paclitaxel\/Bevacizumab (AB160) nano-immunoconjugate therapy for gynecologic malignancies. Clin Cancer Res. 2024. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-3196.","journal-title":"Clin Cancer Res"},{"key":"3623_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202301956","author":"UM Musazzi","year":"2023","unstructured":"Musazzi UM, Franz\u00e8 S, Condorelli F, Minghetti P, Caliceti P. Feeding next-generation nanomedicines to Europe: regulatory and quality challenges. Adv Healthc Mater. 2023. https:\/\/doi.org\/10.1002\/adhm.202301956.","journal-title":"Adv Healthc Mater"},{"key":"3623_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/nano15171354","author":"A Abughalia","year":"2025","unstructured":"Abughalia A, Flynn M, Clarke PFA, Fayne D, Gobbo OL. The use of computational approaches to design nanodelivery systems. Nanomaterials. 2025. https:\/\/doi.org\/10.3390\/nano15171354.","journal-title":"Nanomaterials"},{"key":"3623_CR142","doi-asserted-by":"publisher","DOI":"10.2174\/0115680266373236250411060857","author":"T Zhu","year":"2025","unstructured":"Zhu T, Liu B, Chen N, Liu Y, Wang Z, Tian X. Artificial intelligence-driven innovations in pharmaceutical development and drug delivery systems. Curr Top Med Chem. 2025. https:\/\/doi.org\/10.2174\/0115680266373236250411060857.","journal-title":"Curr Top Med Chem"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03623-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:15:56Z","timestamp":1770124556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03623-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3623"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03623-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"201"}}